Inventor
MARTIN FRANK
US26 patents
⚠️ This page may combine multiple inventors who share the name “MARTIN FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
4 patentsUS7795413B2Sep 14, 2010
Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
AMGEN INC55 citations96
US7718776B2May 18, 2010
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
AMGEN INC47 citations96
US7601818B2Oct 13, 2009
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
AMGEN INC72 citations96
US8367063B2Feb 5, 2013
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
AMGEN INC0 citations50
BECTON DICKINSON CO
4 patentsUS11116900B2Sep 14, 2021
Continuous glucose monitoring injection device
BECTON DICKINSON CO14 citations84
US10252002B2Apr 9, 2019
Continuous glucose monitoring injection device
BECTON DICKINSON CO12 citations82
US10195344B2Feb 5, 2019
Valve permitting mixing in a drug delivery device
BECTON DICKINSON CO4 citations71
US10434264B2Oct 8, 2019
Needle assembly for mixing of substances
BECTON DICKINSON CO0 citations51
WILD JR KENNETH D
3 patentsUS8106167B2Jan 31, 2012
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
WILD JR KENNETH D54 citations95
US8198410B2Jun 12, 2012
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
WILD JR KENNETH D19 citations90
US9260514B2Feb 16, 2016
Methods of treating conditions caused by increased expression of nerve growth factor (NGF) or increased sensitivity to NGF using anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
WILD JR KENNETH D0 citations49